These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10082239)

  • 21. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
    Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
    Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone-induced retrograde ejaculation.
    Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
    Am J Psychiatry; 2001 Apr; 158(4):650. PubMed ID: 11282707
    [No Abstract]   [Full Text] [Related]  

  • 23. Pancreatitis and cholestatic hepatitis induced by risperidone.
    Cordeiro Q; Elkis H
    J Clin Psychopharmacol; 2001 Oct; 21(5):529-30. PubMed ID: 11593080
    [No Abstract]   [Full Text] [Related]  

  • 24. [Remission of schizophrenic psychosis with negative symptoms with risperidone].
    Lübbe R
    Fortschr Med; 1996 Feb; 114(6):35-6. PubMed ID: 8900527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angioedema - an unusual serious side effect of risperidone injection.
    Güneş F; Batgi H; Akbal A; Canatan T
    Clin Toxicol (Phila); 2013 Feb; 51(2):122-3. PubMed ID: 23336748
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute dystonia induced by rapid increase in risperidone dosage.
    Brody AL
    J Clin Psychopharmacol; 1996 Dec; 16(6):461-2. PubMed ID: 8959475
    [No Abstract]   [Full Text] [Related]  

  • 27. Prolactogenic effects of risperidone in male patients--a preliminary study.
    Shiwach RS; Carmody TJ
    Acta Psychiatr Scand; 1998 Jul; 98(1):81-3. PubMed ID: 9696519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabbit syndrome secondary to risperidone.
    Hoy JS; Alexander B
    Pharmacotherapy; 2002 Apr; 22(4):513-5. PubMed ID: 11939686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risperidone Induced Isolated Thrombocytopenia: A Rare Adverse Event.
    Bhattacharjee D; Yerrapragada D; Chogtu B; Thomson SR
    Psychopharmacol Bull; 2018 Mar; 48(3):47-49. PubMed ID: 29713106
    [No Abstract]   [Full Text] [Related]  

  • 30. A case of neuroleptic malignant syndrome with clozapine and risperidone.
    Beauchemin MA; Millaud F; Nguyen KA
    Can J Psychiatry; 2002 Nov; 47(9):886. PubMed ID: 12500761
    [No Abstract]   [Full Text] [Related]  

  • 31. Risperidone-associated agranulocytosis.
    Finkel B; Lerner AG; Oyffe I; Sigal M
    Am J Psychiatry; 1998 Jun; 155(6):855-6. PubMed ID: 9619165
    [No Abstract]   [Full Text] [Related]  

  • 32. Risperidone: switching from brand name to generic.
    Hardan AY; Fung LK; Amin H
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):457-8. PubMed ID: 20973719
    [No Abstract]   [Full Text] [Related]  

  • 33. Risperidone and tardive dyskinesia: a case report.
    Addington DE; Toews JA; Addington JM
    J Clin Psychiatry; 1995 Oct; 56(10):484-5. PubMed ID: 7559377
    [No Abstract]   [Full Text] [Related]  

  • 34. Risperidone-induced tardive dyskinesia.
    Hong KS; Cheong SS; Woo JM; Kim E
    Am J Psychiatry; 1999 Aug; 156(8):1290. PubMed ID: 10450277
    [No Abstract]   [Full Text] [Related]  

  • 35. Risperidone-induced tardive dyskinesia in first-episode psychotic patients.
    Campbell M
    J Clin Psychopharmacol; 1999 Jun; 19(3):276-7. PubMed ID: 10350038
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical profile of an atypical antipsychotic: risperidone.
    Davis JM; Chen N
    Schizophr Bull; 2002; 28(1):43-61. PubMed ID: 12047021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of leptin to the formation of neuroleptic obesity in patients with schizophrenia during antipsychotic therapy.
    Gorobets LN
    Bull Exp Biol Med; 2008 Sep; 146(3):348-50. PubMed ID: 19240857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rabbit syndrome: state of the art.
    Catena M; Fagiolini A; Consoli G; Ducci F; Carlini M; Picchetti M; Marazziti D
    Curr Clin Pharmacol; 2007 Sep; 2(3):212-6. PubMed ID: 18690867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
    Srivastava A; Borkar HA; Chandak S
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.